Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
84
datasets available to search
ShareScore release 0.9.0
Dataset results
84 results for “pediatric lymphoma”
Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients
ClinicalTrials.gov study NCT03610724. IPD Sharing: YES. Countries: 14. Publications: 1.
Study of Brentuximab Vedotin (SGN-35) in Pediatric Participants With Relapsed or Refractory (r/r) Systemic Anaplastic Large-Cell Lymphoma or Hodgkin Lymphoma
ClinicalTrials.gov study NCT01492088. IPD Sharing: YES. Countries: 8. Publications: 3.
A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma
ClinicalTrials.gov study NCT02979522. IPD Sharing: YES. Countries: 4. Publications: 1.
Pediatric chest lymphoma with segmentation
<p>30 CT scans from 30 different pediatric patients diagnosed with any type of lymphoma were collected. All patients were hospitalized between the years 2013 and 2020. One CT scan per patient was included to maximize potential variance in the data and increase model generalizability. There were 17 boys and 13 girls in the study group, and the mean age was 12.8 (SD 4.1, minimum age 2, maximum age 17).</p> <p>Subsequently, two radiology residents performed segmentation of thoracic lymph nodes in 3D Slicer software. <br> The first 17 segmentations were performed manually. Then, an initial model was trained on these scans and used to perform initial segmentations on the remaining 13 scans to accelerate the process. All initial segmentations were subsequently reviewed by the radiology residents responsible for segmentation, and necessary adjustments were made.</p> <p>Dataset consists of raw CT scans and accompanying segmentation. </p> <p>Dataset publication and collection were funded by Polish National Science Centre grant 2020/36/T/NZ5/00515</p>
Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK)
ClinicalTrials.gov study NCT01742286. IPD Sharing: NO. Countries: 10. Publications: 2.
Therapy for Pediatric Hodgkin Lymphoma
ClinicalTrials.gov study NCT00145600. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Tri
ClinicalTrials.gov study NCT03233204. IPD Sharing: UNDECIDED. Countries: 2. Publications: 2.
Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Tre
ClinicalTrials.gov study NCT03213691. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Study in Pediatrics With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma
ClinicalTrials.gov study NCT02227108. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
ClinicalTrials.gov study NCT03213678. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
ClinicalTrials.gov study NCT03210714. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02703272. IPD Sharing: Not stated. Countries: 20. Publications: 2.
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)
ClinicalTrials.gov study NCT03220035. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
ClinicalTrials.gov study NCT03698994. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Scre
ClinicalTrials.gov study NCT03155620. IPD Sharing: Not stated. Countries: 4. Publications: 3.
SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma
ClinicalTrials.gov study NCT01574274. IPD Sharing: Not stated. Countries: 2. Publications: 3.
Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma"
ClinicalTrials.gov study NCT04213209. IPD Sharing: YES. Countries: 1. Publications: 0.
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Tria
ClinicalTrials.gov study NCT03213652. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Information Support Using an Online Learning Platform for Malaysian Pediatric Leukemia and Lymphoma Parents
ClinicalTrials.gov study NCT05455268. IPD Sharing: NO. Countries: 1. Publications: 2.
Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours
ClinicalTrials.gov study NCT02343718. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.